AZ3391 |
Katalog-Nr.GC65899 |
AZ3391 ist ein potenter Inhibitor von PARP. AZ3391 ist ein Chinoxalin-Derivat. Die PARP-Enzymfamilie spielt eine wichtige Rolle bei einer Reihe von zellulÄren Prozessen, wie Replikation, Rekombination, Chromatin-Umbau und Reparatur von DNA-SchÄden. AZ3391 hat das Potenzial fÜr die Erforschung von Krankheiten und ZustÄnden, die in Geweben des zentralen Nervensystems wie Gehirn und RÜckenmark auftreten (aus Patent WO2021260092A1, Verbindung 23).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2756333-42-1
Sample solution is provided at 25 µL, 10mM.
AZ3391 is a potent inhibitor of PARP. AZ3391 is a quinoxaline derivative. PARP family of enzymes play an important role in a number of cellular processes, such as replication, recombination, chromatin remodeling, and DNA damage repair. AZ3391 has the potential for the research of diseases and conditions occurring in tissues in the central nervous system, such as the brain and spinal cord (extracted from patent WO2021260092A1, compound 23)[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *